Pfizer Inc. (PFE) Q1 2013 Earnings Results

Pfizer Misses on EPS, Stock Down 4.47%

Pfizer's earnings report showed a slight miss on EPS, which contributed to a notable drop in stock price by 4.47%. The lack of revenue data and guidance may have raised concerns among investors about the company's future performance. Overall, the market reaction reflects uncertainty regarding Pfizer's upcoming quarters.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.54	N/A	-1.82%

Management

Management commentary

Tone: Defensive

Overall, management expressed concerns about market conditions but did not offer detailed insights into future performance.

Management did not provide specific guidance for future quarters.

The company acknowledged challenges in the current market environment.

Pfizer Misses on EPS, Stock Down 4.47%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Misses on EPS, Stock Down 4.47%

Key numbers

Management commentary